Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Endocrinology | Obstetrics/Gynecology

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Esclim

Company: Fournier Research
Approval Status: Approved August 1998
Treatment Area: Menopause

General Information

Esclim (Estradiol Transdermal System) is can be used in the treatment of the following:

  • Treatment of moderate to severe vasomotor symptoms associated with menopause
  • Treatment of vulval and vaginal atrophy
  • Treatment of certain conditions in which a young woman's ovaries do not produce enough estrogen naturally
  • Treatment of certain types of abnormal vaginal bleeding due to hormonal imbalance in the cases where doctors have found no serious causes for the bleeding
  • Treatment of certain cancers in special situations, in men and women
  • To prevent the thinning of bones

Side Effects

Side effects that occurred when using this system include: headaches, nausea and vomiting, breast tenderness or enlargement, enlargement of benign tumors ("fibroids") of the uterus, retention of excess fluid (may worsen some conditions such as asthma, epilepsy, migraine, heart disease or kidney disease), spotty darkening of the skin (particularly on the face), or skin irritation ( a redness or rash that appears at the application site).


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.